Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies
Open accessThe DOI matches its Crossref record; 211 of the 212 references it cites were found in a registry or an index.
Abstract
Enhancement of brain-derived neurotrophic factor (BDNF) signalling has great potential in therapy for neurological and psychiatric disorders. This neurotrophin not only attenuates cell death but also promotes neuronal plasticity and function. However, an important challenge to this approach is the persistence of aberrant neurotrophic signalling due to a defective function of the BDNF high-affinity receptor, tropomyosin-related kinase B (TrkB), or downstream effectors. Such changes have been already described in several disorders, but their importance as pathological mechanisms has been frequently underestimated. This review highlights the relevance of an integrative characterization of aberrant BDNF/TrkB pathways for the rational design of therapies that by combining BDNF and TrkB targets could efficiently promote neurotrophic signalling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recombinant BDNF performs poorly in humans due to rapid degradation, limited brain penetration, and unstable exposure profiles [122,123,125].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [123]
Experimental — accuracy not yet measuredIn the citing paper
“The transcription of BDNF is dependent upon activation of the cyclic adenosine monophosphate (cAMP) response element binding protein (CREB) protein which plays a critical role in LTP and synaptic plasticity142, 143.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [143]
In the citing paper
“These changes decrease BDNF axonal transport, resulting in reduced availability of BDNF within the synaptic cleft and consequently diminished signaling through TrkB receptors [137, 138].”
From Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation (2019) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
The Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,566
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 1×
“Simultaneously, it has been shown that the therapeutic effects of antidepressants require the action of the BDNF/TrkB pathway [152] and, furthermore, that centrally administered BDNF provides a similar effect to antidepressants in animal models of depression [153].”
BackgroundNestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Exercise: a behavioral intervention to enhance brain health and plasticity
Cotman, C. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02143-4 · Cited by 2,739 · cited 1×
“For example, physical exercise evokes a significant increase of BDNF levels in rat hippocampus and cerebral cortex [187] which is mediated by brain uptake of circulating insulin-like growth factor I (IGF-I) [188].”
BackgroundGordon, M. O. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.6.714 · Cited by 2,626 · cited 1×
“The most important risk factor for glaucoma is intraocular pressure [169].”
BackgroundTrk Receptors: Roles in Neuronal Signal Transduction
Huang, E. J., & Reichardt, L. F. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161629 · Cited by 2,537 · cited 1×
“Binding of BDNF to TrkB-FL induces the receptor dimerization and activation, and results in the recruitment of proteins that trigger three main signal transduction cascades which are widely interconnected (Figure 1) [5].”
BackgroundNibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 2×
“Moreover, antidepressants also upregulate the expression of TrkB mRNA [150] and induce a rapid activation of this receptor and the PLCγ mediated signalling [151].”
BackgroundResultNMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 1×
“More recently, it has been discovered that the NMDAR antagonist, ketamine, produces faster (within hours) antidepressant responses in MDD patients resistant to conventional treatments, concurrent with an increase in the number and function of synaptic connections and enhancement of BDNF expression [191].”
BackgroundBonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,901 · cited 1×
“Shc also triggers the action of the MAPK/ERK pathway, which promotes neuronal differentiation and survival through suppression of the proapoptotic protein BAD and activation of the transcription factor CREB (cAMP response-element binding protein) [7].”
BackgroundNMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609 · cited 1×
“independent of NMDAR inhibition but require AMPAR activation, while lacks ketamine unwanted side effects [192].”
BackgroundRole of Rab GTPases in Membrane Traffic and Cell Physiology
Hutagalung, A. H., & Novick, P. J. (2011) · Physiological Reviews · doi:10.1152/physrev.00059.2009 · Cited by 1,460 · cited 3×
“Furthermore, induction by mutant Htt of deficient Rab11 activity [114] could reduce TrkB cell surface availability since this GTPase is typically involved in TrkB-FL endosomal recycling [21,115].”
BackgroundSen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232 · cited 1×
“Studies with antidepressants also support the neurotrophic hypothesis of depression, since chronic treatment with them increases blood BDNF levels in patients [148,149].”
ResultBrunet, A., Datta, S. R., & Greenberg, M. E. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00211-7 · Cited by 1,188 · cited 1×
“This is the initial step for activation of the PI3K/Akt cascade that controls the activity of several proteins essential for neuronal survival, such as BAD (Bcl-2 antagonist of cell death) or GSK-3β (Glycogen Synthase Kinase 3 β) [6].”
BackgroundGauthier, L. R., Charrin, B. C., Borrell-Pagès, M., Dompierre, J. P., Rangone, H., Cordelières, F. P., De Mey, J., MacDonald, M. E., Leßmann, V., Humbert, S., et al. (2004) · Cell · doi:10.1016/j.cell.2004.06.018 · Cited by 1,178 · cited 3×
“Remarkably, wild-type Htt is part of the motor complex responsible for anterograde and retrograde transport of BDNF-containing vesicles along microtubules [94].”
BackgroundLoss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease
Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., Conti, L., MacDonald, M. E., Friedlander, R. M., Silani, V., Hayden, M. R., et al. (2001) · Science · doi:10.1126/science.1059581 · Cited by 1,123 · cited 2×
“In addition to controlling neurotrophin transport, wild-type Htt also enhances Bdnf expression from promoter II [93] by sequestering repressor element-1 transcription factor/neuron-restrictive silencer factor (REST/NRSF) in the cytoplasm, suppressing its inhibitory transcriptional activity [105].”
BackgroundNucifora, F. C., Sasaki, M., Peters, M. F., Huang, H., Cooper, J. K., Yamada, M., Takahashi, H., Tsuji, S., Troncoso, J., Dawson, V. L., et al. (2001) · Science · doi:10.1126/science.1056784 · Cited by 1,094 · cited 2×
“Additionally, the expanded polyQ Htt generates a more repressive transcriptional environment for Bdnf by recruiting the methyl-CpG binding protein 2 (MeCP2) to promoter IV [107], also sequestering the transcriptional coactivator CREB binding protein (CBP) [108].”
BackgroundHuntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes
Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B. R., Hayden, M. R., Timmusk, T., et al. (2003) · Nature Genetics · doi:10.1038/ng1219 · Cited by 979 · cited 3×
“In contrast, mutant Htt is unable to retain REST/NRSF [105], leading to a reduction of BDNF mRNA levels in the cortex of HD patients [106].”
BackgroundBrunoni, A. R., Lopes, M., & Fregni, F. (2008) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009309 · Cited by 972 · cited 1×
“Studies with antidepressants also support the neurotrophic hypothesis of depression, since chronic treatment with them increases blood BDNF levels in patients [148,149].”
ResultBDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
Phillips, H. S., Hains, J. M., Armanini, M., Laramee, G. R., Johnson, S. A., & Winslow, J. W. (1991) · Neuron · doi:10.1016/0896-6273(91)90273-3 · Cited by 921 · cited 1×
“The decrease of BDNF mRNA is an important mechanism of neurotrophin loss in AD brain (Figure 3a), observed in hippocampus [53], basal forebrain [54], and temporal [55] and parietal cortices [56].”
BackgroundConvergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 913 · cited 6×
“Impairment of TrkB-FL activity by Shp-2 action might also contribute to ERK1/2 inactivation in neurons.”
BackgroundInfluentialDwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.8.804 · Cited by 875 · cited 1×
“Interestingly, the reduction of BDNF and the two major TrkB isoforms is also evident in the postmortem brain of suicide victims [154,155], generally having a high incidence of previous major depression.”
BackgroundAntidepressant-like effect of brain-derived neurotrophic factor (BDNF)
Siuciak, J. A., Lewis, D. R., Wiegand, S. J., & Lindsay, R. M. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00169-4 · Cited by 841 · cited 1×
“Simultaneously, it has been shown that the therapeutic effects of antidepressants require the action of the BDNF/TrkB pathway [152] and, furthermore, that centrally administered BDNF provides a similar effect to antidepressants in animal models of depression [153].”
BackgroundDompierre, J. P., Godin, J. D., Charrin, B. C., Cordelières, F. P., King, S. J., Humbert, S., & Saudou, F. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0037-07.2007 · Cited by 792
Circulating Insulin-Like Growth Factor I Mediates Effects of Exercise on the Brain
Carro, E., Nuñez, A., Busiguina, S., & Torres-Aleman, I. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02926.2000 · Cited by 762
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases
Lu, B., Nagappan, G., Guan, X., Nathan, P. J., & Wren, P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3505 · Cited by 743 · cited 1×
“Particularly, in the case of neurological disorders, the recovery of neurotrophic signalling could be not only neuroprotective but also promote adult neurogenesis (reviewed in [181]) or synaptic plasticity and growth [182], which are altered in many of these diseases.”
BackgroundDuman, R. S., & Voleti, B. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.004 · Cited by 714 · cited 1×
“Thus, both gradually and rapid acting antidepressants reverse the significant decrease of BDNF levels characteristic of MDD patients [193] and promote TrkB signalling, synaptic plasticity and neuronal excitability.”
BackgroundPeng, S., Wuu, J., Mufson, E. J., & Fahnestock, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03135.x · Cited by 691 · cited 2×
“deposition) and correlates with memory deficits [57,58], strongly suggesting the relevance of those changes for the synaptic loss and cell dysfunction underlying AD cognitive impairment.”
BackgroundA selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone
Jang, S.-W., Liu, X., Yepes, M., Shepherd, K. R., Miller, G. W., Liu, Y., Wilson, W. D., Xiao, G., Blanchi, B., Sun, Y. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913572107 · Cited by 686 · cited 2×
“Another strategy has consisted in the development of small-size TrkB agonists alternative to BDNF, or BDNF mimetics, such as 7,8-dihydroxyflavone (7,8-DHF), an stable molecule able to efficiently cross the BBB after oral administration [198].”
BackgroundExcitotoxicity: Bridge to various triggers in neurodegenerative disorders
Mehta, A., Prabhakar, M., Kumar, P., Deshmukh, R., & Sharma, P. L. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.10.032 · Cited by 665
Linking Molecules to Mood: New Insight Into the Biology of Depression
Krishnan, V., & Nestler, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.10030434 · Cited by 643 · cited 1×
“Several lines of evidence indicate that it may be associated with the inability of neuronal systems to exhibit adaptive plasticity, and highlight the reduction in neurotrophic signalling as one central disease mechanism (reviewed in reference [146]).”
BackgroundObstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma.
Pease, M. E., McKinnon, S. J., Quigley, H. A., Kerrigan, L. A., & Zack, D. J. (2000) · PubMed · Cited by 588
Saito, K., Elce, J. S., Hamos, J. E., & Nixon, R. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2628 · Cited by 583 · cited 2×
“One prominent effector of this deathly Aβ activity is calpain which is overstimulated in postmortem AD brains [66].”
BackgroundDendritic spine pathology in schizophrenia
Glausier, J. R., & Lewis, D. A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.044 · Cited by 581 · cited 1×
“Schizophrenia patients suffer impairments in perception, cognition and motivation that reflect, at least in part, deficits in dendritic spines [158].”
BackgroundBrain-derived neurotrophic factor is reduced in Alzheimer's disease
Connor, B., Young, D., Yan, Q., Faull, R. L. M., Synek, B., & Dragunow, M. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00125-3 · Cited by 581
Quigley, H. A., McKinnon, S. J., Zack, D. J., Pease, M. E., Kerrigan, L. A., Kerrigan, D., & Mitchell, R. S. (2000) · PubMed · Cited by 569
Chalecka-Franaszek, E., & Chuang, D.-M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8745 · Cited by 542 · cited 1×
“Similarly, exposure to excitotoxic concentrations of glutamate inhibits PI3K/Akt and is followed by subsequent GSK-3β activation [41].”
BackgroundVitolo, O. V., Sant'Angelo, A., Costanzo, V., Battaglia, F., Arancio, O., & Shelanski, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172504199 · Cited by 534 · cited 1×
“Additionally, protein kinase A (PKA), a major CREB regulator, is inactivated in the temporal cortex of AD patients [74,75] by Aβ action [76].”
BackgroundReduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia
Weickert, C. S., Hyde, T. M., Lipska, B. K., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001308 · Cited by 532 · cited 1×
“Simultaneously, alterations in BDNF protein [160,161] and total mRNA have been observed in postmortem prefrontal cortex from patients [161,162].”
BackgroundHock, C., Heese, K., Hulette, C., Rosenberg, C., & Otten, U. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.846 · Cited by 523
Critical Role of Brain-Derived Neurotrophic Factor in Mood Disorders
Hashimoto, K., Shimizu, E., & Iyo, M. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.02.003 · Cited by 522 · cited 4×
“Thus, both gradually and rapid acting antidepressants reverse the significant decrease of BDNF levels characteristic of MDD patients [193] and promote TrkB signalling, synaptic plasticity and neuronal excitability.”
InfluentialReduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra
Howells, D. W., Porritt, M. J., Wong, J. Y. F., Batchelor, P. E., Kalnins, R., Hughes, A. J., & Donnan, G. A. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7483 · Cited by 513 · cited 6×
“Postmortem studies of PD patients reveal a reduction of BDNF mRNA and protein in the vulnerable region SNpc [121,122] and also the striatum [123], which receives neurotrophic support from the SN [95].”
BackgroundInfluentialHumbert, S., Bryson, E. A., Cordelières, F. P., Connors, N. C., Datta, S. R., Finkbeiner, S., Greenberg, M. E., & Saudou, F. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00188-0 · Cited by 509 · cited 2×
“The phosphorylation of wild-type Htt in Ser421 by Akt promotes the anterograde movement of vesicles [101], mediates IGF-1 neuroprotective effects in HD [102] and mitigates the toxicity of mutant Htt by increasing its proteasome-dependent turnover [103].”
BackgroundMechanism of TrkB-Mediated Hippocampal Long-Term Potentiation
Minichiello, L., Calella, A. M., Medina, D. L., Bonhoeffer, T., Klein, R., & Korte, M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00942-x · Cited by 506 · cited 1×
“The recruitment and activation of PLCγ (Phospholipase C γ) through phosphorylation of TrkB residue Tyr816 also promotes neuronal survival and is implicated in neurite outgrowth and synaptic plasticity [9].”
BackgroundRab5 and Rab7 Control Endocytic Sorting along the Axonal Retrograde Transport Pathway
Deinhardt, K., Salinas, S., Verastegui, C., Watson, R., Worth, D., Hanrahan, S., Bucci, C., & Schiavo, G. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.018 · Cited by 467 · cited 1×
“Since late endosomes control TrkB receptor retrograde delivery [134], this observation could explain the shift in receptor subcellular location found in PD [125] and mentioned before.”
BackgroundMEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia
Alessandrini, A., Namura, S., Moskowitz, M. A., & Bonventre, J. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12866 · Cited by 464 · cited 1×
“However, sustained ERK1/2 phosphorylation has been detected in the penumbra area after acute ischemic stroke in humans [38] and animal models [39], where it seems to contribute to brain injury [40].”
BackgroundBDNF and epilepsy: too much of a good thing?
Binder, D. K., Croll, S. D., Gall, C. M., & Scharfman, H. E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01682-9 · Cited by 454
Glutamatergic Mechanisms Associated with Seizures and Epilepsy
Barker-Haliski, M., & White, H. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022863 · Cited by 442
Gong, B., Cao, Z., Zheng, P., Vitolo, O. V., Liu, S., Staniszewski, A., Moolman, D., Zhang, H., Shelanski, M., & Arancio, O. (2006) · Cell · doi:10.1016/j.cell.2006.06.046 · Cited by 420
Ferrer, I., Marín, C., Rey, M. J., Ribalta, T., Goutan, E., Blanco, R., Tolosa, E., & Martí, E. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199907000-00007 · Cited by 407 · cited 2×
“The decrease of TrkB-FL could be aggravated by the upregulation of truncated receptor isoforms TrkB-T1 and TrkB-Shc in AD brains (Figure 3c), taking place in frontal [61] and temporal lobes or the hippocampus [64,65].”
BackgroundHashimoto, T., Bergen, S. E., Nguyen, Q. L., Xu, B., Monteggia, L. M., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4035-04.2005 · Cited by 384 · cited 2×
“Additionally, decreased levels of TrkB mRNA [162,164] and protein, together with reduced activity of TrkB downstream effectors Akt and ERK1/2 [165,166], have been reported in the prefrontal cortex of schizophrenia patients.”
BackgroundSynaptic and neuritic alterations during the progression of Alzheimer's disease
Masliah, E., Mallory, M., Hansen, L., Richard, D., Alford, M., & Terry, R. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90121-x · Cited by 370
Bhat, R. V., Shanley, J., Correll, M. P., Fieles, W. E., Keith, R. A., Scott, C. W., & Lee, C.-M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190297597 · Cited by 366 · cited 1×
“Transient focal ischemia tends to activate GSK-3β and subsequently induce apoptotic cell death [42], whereas permanent cerebral ischemia rapidly suppresses it for 24 h after damage [43].”
BackgroundBrain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses
Durany, N., Michel, T., Zöchling, R., Boissl, K. W., Cruz-Sánchez, F. F., Riederer, P., & Thome, J. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00084-0 · Cited by 362 · cited 1×
“Simultaneously, alterations in BDNF protein [160,161] and total mRNA have been observed in postmortem prefrontal cortex from patients [161,162].”
Martin, K. R. G., Quigley, H. A., Zack, D. J., Levkovitch-Verbin, H., Kielczewski, J., Valenta, D., Baumrind, L., Pease, M. E., Klein, R. L., & Hauswirth, W. W. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1332 · Cited by 362 · cited 1×
“Several studies have shown that BDNF transiently delays RGC death in glaucoma [172,173].”
BackgroundColin, E., Zala, D., Liot, G., Rangone, H., Borrell‐Pagès, M., Li, X., Saudou, F., & Humbert, S. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.133 · Cited by 360 · cited 1×
“The phosphorylation of wild-type Htt in Ser421 by Akt promotes the anterograde movement of vesicles [101], mediates IGF-1 neuroprotective effects in HD [102] and mitigates the toxicity of mutant Htt by increasing its proteasome-dependent turnover [103].”
BackgroundHuntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin
Engelender, S. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.13.2205 · Cited by 341 · cited 3×
“In those complexes, Htt is associated with dynactin subunit p150Glued via Htt-associated protein 1 (HAP1) [96,97] or directly with dynein [98].”
BackgroundThoenen, H., & Sendtner, M. (2002) · Nature Neuroscience · doi:10.1038/nn938 · Cited by 336 · cited 2×
“These failures have been attributed to the multimodal nature of disease progression, poor neurotrophin delivery to appropriate targets due to limited blood–brain barrier (BBB) permeability and tissue diffusion, short serum half-lives and side effects [3].”
BackgroundHuntingtin facilitates dynein/dynactin-mediated vesicle transport
Caviston, J. P., Ross, J. L., Antony, S. M., Tokito, M., & Holzbaur, E. L. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610628104 · Cited by 331 · cited 1×
“In those complexes, Htt is associated with dynactin subunit p150Glued via Htt-associated protein 1 (HAP1) [96,97] or directly with dynein [98].”
BackgroundBrain-derived neurotrophic factor in Huntington disease
Ferrer, I., Goutan, E., Marı́n, C., Rey, M. J., & Ribalta, T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02237-x · Cited by 331 · cited 1×
“Reduced levels of striatal BDNF protein have been detected in HD patients at symptomatic disease stages [92] which are the result of decreased neurotrophin expression [93] and disrupted corticostriatal transportation [94].”
BackgroundCalpain Activation in Huntington's Disease
Gafni, J., & Ellerby, L. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04842.2002 · Cited by 331
Holsinger, R. M. D., Schnarr, J., Henry, P., Castelo, V. T., & Fahnestock, M. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00023-1 · Cited by 328 · cited 1×
“The decrease of BDNF mRNA is an important mechanism of neurotrophin loss in AD brain (Figure 3a), observed in hippocampus [53], basal forebrain [54], and temporal [55] and parietal cortices [56].”
BackgroundIvanov, A., Pellegrino, C., Rama, S., Dumalska, I., Salyha, Y., Ben‐Ari, Y., & Medina, I. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.105510 · Cited by 319
Neurotrophin trafficking by anterograde transport
Altar, C. A., & DiStefano, P. S. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01273-9 · Cited by 319 · cited 2×
“Postmortem studies of PD patients reveal a reduction of BDNF mRNA and protein in the vulnerable region SNpc [121,122] and also the striatum [123], which receives neurotrophic support from the SN [95].”
BackgroundNeurotrophin signalling pathways regulating neuronal apoptosis
Miller, F. D., & Kaplan, D. R. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000919 · Cited by 317 · cited 1×
“These receptor systems are frequently co-expressed in the same cells and can form heteromeric complexes that change their affinity for mature neurotrophins [17].”
BackgroundRantamäki, T., Hendolin, P., Kankaanpää, A., Mijatovic, J., Piepponen, P., Domenici, E., Chao, M. V., Männistö, P. T., & Castrén, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301345 · Cited by 305
Parain, K., Murer, M. G., Yan, Q., Faucheux, B., Agid, Y., Hirsch, E., & Raisman-Vozari, R. (1999) · NeuroReport · doi:10.1097/00001756-199902250-00021 · Cited by 303 · cited 6×
“Postmortem studies of PD patients reveal a reduction of BDNF mRNA and protein in the vulnerable region SNpc [121,122] and also the striatum [123], which receives neurotrophic support from the SN [95].”
BackgroundInfluentialOchs, G., Penn, R. D., York, M., Giess, R., Beck, M., Tonn, J., Haigh, J., Malta, E., Traub, M., Sendtner, M., et al. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515197 · Cited by 302 · cited 2×
“Thus, intrathecally administered BDNF in patients of amyotrophic lateral sclerosis (ALS) did not show significant effects on motor function and survival [1] or autonomic nervous system function [2].”
BackgroundXu, J., Kurup, P., Zhang, Y., Goebel-Goody, S. M., Wu, P. H., Hawasli, A. H., Baum, M. L., Bibb, J. A., & Lombroso, P. J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2212-09.2009 · Cited by 280
Biffo, S., Offenhäuser, N., Carter, B. D., & Barde, Y.-A. (1995) · Development · doi:10.1242/dev.121.8.2461 · Cited by 272
Interaction of Huntingtin-Associated Protein with Dynactin P150Glued
Li, S.-H., Gutekunst, C.-A., Hersch, S. M., & Li, X.-J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-04-01261.1998 · Cited by 270 · cited 3×
“In those complexes, Htt is associated with dynactin subunit p150Glued via Htt-associated protein 1 (HAP1) [96,97] or directly with dynein [98].”
BackgroundKokaia, Z., Zhao, Q., Kokaia, M., Elmér, E., Metsis, M., Smith, M.-L., Siesjö, B. K., & Lindvall, O. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1085 · Cited by 252 · cited 1×
“Enhancement of BDNF production after stroke, mainly attributable to perilesional neurons but also to microglia [28], has been suggested as a brain compensatory mechanism to prevent excessive neuronal death [29].”
BackgroundPeng, X. M., Tehranian, R., Dietrich, P., Stefanis, L., & Perez, R. G. (2005) · Journal of Cell Science · doi:10.1242/jcs.02481 · Cited by 249 · cited 1×
“Thus, elevated levels of α-synuclein increase the activity of the Akt inhibitors phosphatase PP2A [135] and RTP801 [136] while Akt phosphorylation is significantly diminished in dopaminergic SN neurons of PD patients [137].”
BackgroundZhang, Z., Liu, X., Schroeder, J. P., Chan, C.-B., Song, M., Yu, S. P., Weinshenker, D., & Ye, K. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.243 · Cited by 242
Calpain-Cleavage of α-Synuclein
Dufty, B. M., Warner, L. R., Hou, S. T., Jiang, S. X., Gomez-Isla, T., Leenhouts, K. M., Oxford, J. T., Feany, M. B., Masliah, E., & Rohn, T. T. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061232 · Cited by 241 · cited 2×
“Thus, calpain activation has been suggested to participate in disease-linked α-synuclein aggregation in PD as well as other α-synucleopathies [144,145].”
BackgroundDownregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons
Pugazhenthi, S., Wang, M., Pham, S., Sze, C.-I., & Eckman, C. B. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-60 · Cited by 237
Ernst, C., Deleva, V., Deng, X., Sequeira, A., Pomarenski, A., Klempan, T., Ernst, N., Quirion, R., Gratton, A., Szyf, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archpsyc.66.1.22 · Cited by 235 · cited 1×
“Interestingly, the reduction of BDNF and the two major TrkB isoforms is also evident in the postmortem brain of suicide victims [154,155], generally having a high incidence of previous major depression.”
BackgroundRegulation of Neurogenesis by Neurotrophins during Adulthood: Expected and Unexpected Roles
Vilar, M., & Mira, H. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00026 · Cited by 235 · cited 1×
“Particularly, in the case of neurological disorders, the recovery of neurotrophic signalling could be not only neuroprotective but also promote adult neurogenesis (reviewed in [181]) or synaptic plasticity and growth [182], which are altered in many of these diseases.”
BackgroundVolpicelli-Daley, L. A., Gamble, K. L., Schultheiss, C. E., Riddle, D. M., West, A. B., & Lee, V. M.-Y. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-02-0741 · Cited by 232
Zuccato, C., Marullo, M., Conforti, P., MacDonald, M. E., Tartari, M., & Cattaneo, E. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00111.x · Cited by 231
Malagelada, C., Jin, Z. H., & Greene, L. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3928-08.2008 · Cited by 228 · cited 1×
“Thus, elevated levels of α-synuclein increase the activity of the Akt inhibitors phosphatase PP2A [135] and RTP801 [136] while Akt phosphorylation is significantly diminished in dopaminergic SN neurons of PD patients [137].”
BackgroundRegional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimerʼs disease
Narisawa-Saito, M., Wakabayashi, K., Tsuji, S., Takahashi, H., & Nawa, H. (1996) · NeuroReport · doi:10.1097/00001756-199611250-00024 · Cited by 226
Molander‐Melin, M., Blennow, K., Bogdanovic, N., Dellheden, B., Månsson, J., & Fredman, P. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02849.x · Cited by 224 · cited 1×
“These results are highly relevant and could facilitate the design of future therapies aimed to enhance BDNF expression in humans, where a decrease in cholesterol content has been also reported in normal aging brain and AD patients [196,197].”
BackgroundTong, L., Balazs, R., Thornton, P. L., & Cotman, C. W. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5463-03.2004 · Cited by 221 · cited 1×
“Other important mechanisms contributing to the deficiency of BDNF/TrkB signalling in AD are the suppression of MAPK/ERK and PI3K/Akt pathways by sub-lethal concentrations of Aβ, without interference of TrkB-FL and PLCγ activation [85], and the disruption of BDNF-induced TrkB endocytosis.”
BackgroundNeuroprotection, Growth Factors and BDNF-TrkB Signalling in Retinal Degeneration
Kimura, A., Namekata, K., Guo, X., Harada, C., & Harada, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091584 · Cited by 211 · cited 1×
“Therefore, besides treatments directed to decrease intraocular pressure, neurotrophic factors are currently considered as having great potential in glaucoma therapy (recently reviewed by [174]).”
BackgroundLiu, G., Gu, B., He, X.-P., Joshi, R. B., Wackerle, H. D., Rodriguiz, R. M., Wetsel, W. C., & McNamara, J. O. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.027 · Cited by 210
BDNF enhances retinal ganglion cell survival in cats with optic nerve damage.
Chen, H., & Weber, A. J. (2001) · PubMed · Cited by 205
Neurotrophic factor control of satiety and body weight
Xu, B., & Xie, X. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.24 · Cited by 203
Regulated neurotrophin receptor responsiveness during neuronal migrationand early differentiation
Knusel, B., Rabin, S., Hefti, F., & Kaplan, D. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-03-01542.1994 · Cited by 202 · cited 1×
“Interestingly, TrkB expression [14] and responsiveness to BDNF are developmentally regulated [15,16].”
BackgroundReductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia
Weickert, C. S., Ligons, D. L., Romanczyk, T., Ungaro, G., Hyde, T. M., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001678 · Cited by 199
β-Amyloid impairs axonal BDNF retrograde trafficking
Poon, W. W., Blurton-Jones, M., Tu, C. H., Feinberg, L. M., Chabrier, M. A., Harris, J. W., Jeon, N. L., & Cotman, C. W. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.012 · Cited by 198
Yamamoto-Sasaki, M., Ozawa, H., Saito, T., Rösler, M., & Riederer, P. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01220-2 · Cited by 198
Akt signal transduction dysfunction in Parkinson's disease
Timmons, S., Coakley, M. F., Moloney, A. M., & O’ Neill, C. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.055 · Cited by 192 · cited 1×
“Thus, elevated levels of α-synuclein increase the activity of the Akt inhibitors phosphatase PP2A [135] and RTP801 [136] while Akt phosphorylation is significantly diminished in dopaminergic SN neurons of PD patients [137].”
BackgroundMutant Huntingtin Alters Retrograde Transport of TrkB Receptors in Striatal Dendrites
Liot, G., Zala, D., Pla, P., Mottet, G., Piel, M., & Saudou, F. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2033-12.2013 · Cited by 192 · cited 1×
“In addition to the transcriptional imbalance, mutant Htt can also alter binding of TrkB-FL-containing vesicles to microtubules and impair retrograde endosomal trafficking in striatal dendrites [113].”
BackgroundImpaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington’s disease
Plotkin, J. L., Day, M., Peterson, J. D., Xie, Z., Kress, G. J., Rafalovich, I., Kondapalli, J., Gertler, T. S., Flajolet, M., Greengard, P., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.032 · Cited by 187 · cited 2×
“The deficiency in BDNF/TrkB downstream signalling observed in HD has been recently revealed to precede the defects in transport and expression of neurotrophin and receptors [117,118].”
BackgroundDaRocha-Souto, B., Coma, M., Pérez-Nievas, B. G., Scotton, T. C., Siao, M., Sánchez-Ferrer, P., Hashimoto, T., Fan, Z., Hudry, E., Barroeta, I., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.002 · Cited by 180 · cited 1×
“Aβ also decreases CREB activity by GSK3β overstimulation [78], which is produced by two mechanisms: decreased GSK3β inhibitory phosphorylation of Ser9 by PKA [79,80] and calpain proteolysis to yield a truncated GSK3β with augmented kinase activity [81,82].”
BackgroundZhu, J., Kulich, S. M., Oury, T. D., & Chu, C. T. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64487-2 · Cited by 169 · cited 1×
“Additionally, human postmortem tissues corresponding to different Lewy body diseases exhibit granular cytoplasmic aggregates of activated ERK in the SN, probably formed early along the disease course, that may affect the accessibility to downstream targets and regulatory phosphatases [139].”
BackgroundArévalo, J. C., Yano, H., Teng, K. K., & Chao, M. V. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600253 · Cited by 168 · cited 1×
“However, the prolonged activation of MAPKs requires binding of the adaptor protein FRS2 at the Tyr515 residue or action of TrkB-interacting protein Kidins220 (Kinase D interacting substrate of 220 kDa) to bring the downstream effectors in the vicinity of TrkB receptors [8].”
BackgroundTime-dependent contribution of non neuronal cells to BDNF production after ischemic stroke in rats
Béjot, Y., Prigent‐Tessier, A., Cachia, C., Giroud, M., Mossiat, C. M., Bertrand, N., Garnier, P. E., & Marie, C. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.10.019 · Cited by 166 · cited 1×
“Enhancement of BDNF production after stroke, mainly attributable to perilesional neurons but also to microglia [28], has been suggested as a brain compensatory mechanism to prevent excessive neuronal death [29].”
BackgroundAkt is altered in an animal model of Huntington's disease and in patients
Colin, E., Régulier, E., Perrin, V., Dürr, A., Brice, A., Aebischer, P., Déglon, N., Humbert, S., & Saudou, F. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03985.x · Cited by 163 · cited 1×
“However, Akt is cleaved by caspase-3 into an inactive form in the postmortem brain of HD patients [102,104] supporting a prominent role for dysfunction of this survival pathway along disease progression.”
BackgroundYuan, P., Zhou, R., Wang, Y., Li, X., Li, J., Chen, G., Guitart, X., & Manji, H. K. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.10.017 · Cited by 161 · cited 6×
“Impairment of TrkB-FL activity by Shp-2 action might also contribute to ERK1/2 inactivation in neurons.”
BackgroundInfluentialTruncated trkB.T1 Is Dominant Negative Inhibitor of trkB.TK+-Mediated Cell Survival
Haapasalo, A., Koponen, E., Hoppe, E., Wong, G., & Ċastrén, E. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4296 · Cited by 158 · cited 1×
“TrkB-T1 opposes TrkB-FL competing for BDNF [10] or forming inactive heterodimers in neurons [11].”
BackgroundMishizen-Eberz, A. J., Rissman, R. A., Carter, T. L., Ikonomovic, M. D., Wolfe, B. B., & Armstrong, D. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.016 · Cited by 156
Ferrer, I., Krupinski, J., Goutan, E., Martí, E., Ambrosio, S., & Arenas, E. (2001) · Acta Neuropathologica · doi:10.1007/s004010000268 · Cited by 153 · cited 4×
“In fact, levels of TrkB-FL diminish dras ically in the inf cted core and penumbra area whereas those of TrkB-T1 are upregulated in human ischemic stroke [32] and animal models of ischemia [26,32].”
BackgroundInfluentialGallegos, S., Pacheco, C. R., Peters, C., Opazo, C., & Aguayo, L. G. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00059 · Cited by 150
Li, X., Valencia, A., Sapp, E., Masso, N., Alexander, J., Reeves, P., Kegel, K. B., Aronin, N., & DiFiglia, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5865-09.2010 · Cited by 147 · cited 1×
“Furthermore, induction by mutant Htt of deficient Rab11 activity [114] could reduce TrkB cell surface availability since this GTPase is typically involved in TrkB-FL endosomal recycling [21,115].”
BackgroundN-terminal Cleavage of GSK-3 by Calpain
Goñi-Oliver, P., Lucas, J. J., Avila, J., & Hernández, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702793200 · Cited by 146 · cited 1×
“Aβ also decreases CREB activity by GSK3β overstimulation [78], which is produced by two mechanisms: decreased GSK3β inhibitory phosphorylation of Ser9 by PKA [79,80] and calpain proteolysis to yield a truncated GSK3β with augmented kinase activity [81,82].”
BackgroundSalehi, A., Verhaagen, J., Dijkhuizen, P. A., & Swaab, D. F. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00273-4 · Cited by 144 · cited 2×
“In addition to BDNF, a decrea e in the TrkB-FL recept r has been found in postmortem AD brains, specifically in the nucleus basalis [60], and frontal [61,62] and temporal cortices [62].”
BackgroundElliott, E., Atlas, R., Lange, A., & Ginzburg, I. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04290.x · Cited by 142
Qin, X.-Y., Cao, C., Cawley, N. X., Liu, T.-T., Yuan, J., Loh, Y. P., & Cheng, Y. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.62 · Cited by 142 · cited 1×
“Regarding the presence of BDNF in serum, while we should be cautious due to some inconsistent results, a recent meta-analysis shows a significant decrease of neurotrophin levels in AD patients compared to healthy subjects [52].”
ResultNeurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms
Crish, S. D., & Calkins, D. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.12.036 · Cited by 141 · cited 1×
“For glaucoma, death of retinal ganglion cells (RGCs) resulting in optic nerve damage and irreversible blindness can be explained by a lack of neurotrophic support [168].”
BackgroundChen, D. C., Wang, J., Wang, B., Yang, S. C., Zhang, C. X., Zheng, Y. L., Li, Y. L., Wang, N., Yang, K. B., Xiu, M. H., et al. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1665-6 · Cited by 140 · cited 1×
“Thus, several studies have shown decreased circulating BDNF levels in individuals with schizophrenia [159].”
BackgroundReduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain
Ginés, S., Bosch, M., Marco, S., Gavaldà, N., Díaz‐Hernández, M., Lucas, J. J., Canals, J. M., & Alberch, J. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04590.x · Cited by 140 · cited 1×
“Consequently, high p75NTR but decreased TrkB-FL protein levels are observed in the striatum from HD patients at late disease stages [109,110].”
BackgroundBDNF Regulates Rab11-Mediated Recycling Endosome Dynamics to Induce Dendritic Branching
Lazo, O. M., Gonzalez, A., Ascaño, M., Kuruvilla, R., Couve, A., & Bronfman, F. C. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4630-12.2013 · Cited by 137 · cited 1×
“Furthermore, induction by mutant Htt of deficient Rab11 activity [114] could reduce TrkB cell surface availability since this GTPase is typically involved in TrkB-FL endosomal recycling [21,115].”
BackgroundPorritt, M. J., Batchelor, P. E., & Howells, D. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.030 · Cited by 135
Dorsey, S. G., Renn, C. L., Carim‐Todd, L., Barrick, C. A., Bambrick, L. L., Krueger, B. K., Ward, C. W., & Tessarollo, L. (2006) · Neuron · doi:10.1016/j.neuron.2006.06.009 · Cited by 134
Liang, Z., Liu, F., Grundke‐Iqbal, I., Iqbal, K., & Gong, C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04942.x · Cited by 134
Alderson, R. F., Curtis, R., Alterman, A. L., Lindsay, R. M., & DiStefano, P. S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02428-8 · Cited by 133 · cited 1×
“Thus, the isoform present in glial cells can regulate the local concentration of BDNF [12] and is involved in cell morphology through interaction with Rho GDI (Rho GDP dissociation inhibitor 1) [13].”
BackgroundNeurotrophic factors and Alzheimer’s disease: are we focusing on the wrong molecule?
Fahnestock, M. L., Garzón, D. V., Holsinger, R. M. D., & Michalski, B. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_22 · Cited by 129
Ohira, K., Kumanogoh, H., Sahara, Y., Homma, K. J., Hirai, H., Nakamura, S., & Hayashi, M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4436-04.2005 · Cited by 127
Yuan, Y., Yan, W.-F., Sun, J., Huang, J., Mu, Z., & Chen, N. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.11.029 · Cited by 124 · cited 1×
“Attenuation of Akt phosphorylation leads to GSK3β activation in the presence of α-synuclein aggregates [138].”
BackgroundRantamäki, T., Vesa, L., Antila, H., Di Lieto, A., Tammela, P., Schmitt, A., Lesch, K.-P., Rios, M., & Castrén, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020567 · Cited by 124 · cited 1×
“Brain TrkB transactivation is also achieved by antidepressant drugs in adult mice via unknown mechanisms [16] that result in specific phosphorylation of Tyr816, PLCγ activation and CREB phosphorylation [151], processes that are independent of monoamine transporter inhibition or BDNF action [203].”
BackgroundGéral, C., Angelova, A., & Lesieur, S. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5010127 · Cited by 123
Luberg, K., Wong, J., Weickert, C. S., & Timmusk, T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06662.x · Cited by 123 · cited 1×
“Four TrkB isoforms are expressed in human brain: the full-length receptor (TrkB-FL), two truncated isoforms TrkB-T1 and TrkB-Shc, which lack the tyrosine kinase domain, and TrkB-T-TK, having a non-functional catalytic domain [4].”
BackgroundProfound and Selective Loss of Catalytic TrkB Immunoreactivity in Alzheimer's Disease
Allen, S. J., Wilcock, G. K., & Dawbarn, D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1561 · Cited by 123 · cited 3×
“In addition to BDNF, a decrea e in the TrkB-FL recept r has been found in postmortem AD brains, specifically in the nucleus basalis [60], and frontal [61,62] and temporal cortices [62].”
BackgroundTrk receptor alterations in Alzheimer's disease
Connor, B. J., Young, D., Lawlor, P. A., Gai, W., Waldvogel, H. J., Faull, R. L. M., & Dragunow, M. (1996) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00040-x · Cited by 121 · cited 1×
“The decrease of TrkB-FL could be aggravated by the upregulation of truncated receptor isoforms TrkB-T1 and TrkB-Shc in AD brains (Figure 3c), taking place in frontal [61] and temporal lobes or the hippocampus [64,65].”
BackgroundGrowth Arrest and DNA-Damage-Inducible, Beta (GADD45b)-Mediated DNA Demethylation in Major Psychosis
Gavin, D. P., Sharma, R. P., Chase, K. A., Matrisciano, F., Dong, E., & Guidotti, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.221 · Cited by 121 · cited 1×
“Aberrant DNA methylation might be involved in this altered BDNF regulation, as reduced binding of GADD45b (a growth arrest and DNA-damage-inducible β protein) to one of Bdnf promoters has been observed in psychotic subjects [163].”
BackgroundRobust dysregulation of gene expression in substantia nigra and striatum in Parkinson's disease
Miller, R. M., Kiser, G. L., Kaysser-Kranich, T., Lockner, R., Palaniappan, C., & Federoff, H. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.07.010 · Cited by 119 · cited 1×
“Postmortem studies of PD patients reveal a reduction of BDNF mRNA and protein in the vulnerable region SNpc [121,122] and also the striatum [123], which receives neurotrophic support from the SN [95].”
BackgroundMishizen-Eberz, A. J., Norris, E. H., Giasson, B. I., Hodara, R., Ischiropoulos, H., Lee, V. M.-Y., Trojanowski, J. Q., & Lynch, D. R. (2005) · Biochemistry · doi:10.1021/bi047846q · Cited by 118 · cited 1×
“In addition, calpain also processes α-synuclein [143], a truncation that leads to formation of high-molecular weight aggregates [144].”
BackgroundAutonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF
Beck, M., Flachenecker, P., Magnus, T., Giess, R., Reiners, K., Toyka, K. V., & Naumann, M. (2005) · Amyotrophic Lateral Sclerosis · doi:10.1080/14660820510028412 · Cited by 117 · cited 2×
“Thus, intrathecally administered BDNF in patients of amyotrophic lateral sclerosis (ALS) did not show significant effects on motor function and survival [1] or autonomic nervous system function [2].”
BackgroundQiu, Z., Norflus, F., Singh, B., Swindell, M. K., Buzescu, R., Bejarano, M., Chopra, R., Zucker, B., Benn, C. L., DiRocco, D. P., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511648200 · Cited by 117 · cited 1×
“The upregulation of Sp1 observed in cellular and transgenic models of HD [111] could underlie the increased expression of p75NTR since this gene is regulated by this transcription factor [112].”
BackgroundHung, H.-C., & Lee, E. H. Y. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(96)00062-9 · Cited by 116 · cited 1×
“Nonetheless, the deficiency in BDNF/TrkB survival signalling increases the susceptibility of SN dopaminergic neurons to cytotoxic injury [126,127] and might contribute to PD development.”
BackgroundBrito, V., Giralt, A., Enriquez-Barreto, L., Puigdellívol, M., Suelves, N., Zamora-Moratalla, A., Ballesteros, J. J., Martín, E. D., Dominguez-Iturza, N., Morales, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74809 · Cited by 114
Diepenbroek, M., Casadei, N., Esmer, H., Saido, T. C., Takano, J., Kahle, P. J., Nixon, R. A., Rao, M. V., Melki, R., Pieri, L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu112 · Cited by 114 · cited 1×
“Thus, calpain activation has been suggested to participate in disease-linked α-synuclein aggregation in PD as well as other α-synucleopathies [144,145].”
BackgroundImbalance of neurotrophin receptor isoforms TrkB-FL/TrkB-T1 induces neuronal death in excitotoxicity
Vidaurre, Ó. G., Gascón, S., Deogracias, R., Sobrado, M., Cuadrado, E., Montaner, J., Rodríguez‐Peña, A., & Díaz‐Guerra, M. (2012) · Cell Death and Disease · doi:10.1038/cddis.2011.143 · Cited by 108 · cited 4×
“In fact, levels of TrkB-FL diminish dras ically in the inf cted core and penumbra area whereas those of TrkB-T1 are upregulated in human ischemic stroke [32] and animal models of ischemia [26,32].”
BackgroundInfluentialSelf-citationCholesterol synthesis rate in human hippocampus declines with aging
Thelen, K. M., Falkai, P., Bayer, T. A., & Lütjohann, D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.04.034 · Cited by 107 · cited 1×
“These results are highly relevant and could facilitate the design of future therapies aimed to enhance BDNF expression in humans, where a decrease in cholesterol content has been also reported in normal aging brain and AD patients [196,197].”
BackgroundDysregulation of TrkB Receptors and BDNF Function by Amyloid-β Peptide is Mediated by Calpain
Jerónimo-Santos, A., Vaz, S. H., Parreira, S., Rapaz-Lérias, S., Caetano, A. P., Buée-Scherrer, V., Castrén, E., Valente, C. A., Blum, D., Sebastião, A. M., et al. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhu105 · Cited by 107
Jin, N., Yin, X., Yu, D., Cao, M., Gong, C.-X., Iqbal, K., Ding, F., Gu, X., & Liu, F. (2015) · Scientific Reports · doi:10.1038/srep08187 · Cited by 106 · cited 1×
“Aβ also decreases CREB activity by GSK3β overstimulation [78], which is produced by two mechanisms: decreased GSK3β inhibitory phosphorylation of Ser9 by PKA [79,80] and calpain proteolysis to yield a truncated GSK3β with augmented kinase activity [81,82].”
BackgroundYe, X., Tai, W., & Zhang, D. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.004 · Cited by 102 · cited 1×
“Finally, mitochondrial dysfunction induced by Aβ is an early event in AD also conducting to deficits in BDNF axonal transport [90].”
BackgroundImpaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice
Kemppainen, S., Rantamäki, T., Jerónimo-Santos, A., Lavasseur, G., Autio, H., Karpova, N. N., Kärkkäinen, E., Stavén, S., Miranda, H. V., Outeiro, T. F., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.11.006 · Cited by 100 · cited 3×
“Activation of this protease by Aβ in neuronal cultures i duce a dec ase of TrkB-FL [67] by cleavage ne r the receptor Shc docking site (Figur 3d) [68].”
BackgroundInfluentialGu, B., Huang, Y. Z., He, X.-P., Joshi, R. B., Jang, W., & McNamara, J. O. (2015) · Neuron · doi:10.1016/j.neuron.2015.09.032 · Cited by 100
Zuccato, C., & Cattaneo, E. F. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-45106-5_14 · Cited by 97
Immunoreactive Akt, PI3-K and ERK protein kinase expression in ischemic rat brain
Kitagawa, H., Warita, H., Sasaki, C., Zhang, W. R., Sakai, K., Shiro, Y., Mitsumoto, Y., Mori, T., & Abe, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00676-x · Cited by 97 · cited 2×
“However, sustained ERK1/2 phosphorylation has been detected in the penumbra area after acute ischemic stroke in humans [38] and animal models [39], where it seems to contribute to brain injury [40].”
Backgroundalpha-Synuclein forms a complex with transcription factor Elk-1
Iwata, A., Miura, S., Kanazawa, I., Sawada, M., & Nukina, N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.t01-1-00232.x · Cited by 95
Xie, S.-T., Jin, N., Gu, J., Shi, J., Sun, J., Chu, D., Zhang, L. N., Dai, C., Gu, J., Gong, C., et al. (2016) · Aging Cell · doi:10.1111/acel.12449 · Cited by 94
Brito, V, Puigdellívol, M., Giralt, A., del Toro, D., Alberch, J., & Ginés, S. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.116 · Cited by 93 · cited 1×
“Consequently, high p75NTR but decreased TrkB-FL protein levels are observed in the striatum from HD patients at late disease stages [109,110].”
BackgroundDevi, L., & Ohno, M. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.55 · Cited by 92 · cited 5×
“The inhibition of PKA signalling and, therefore, CREB function is attributed to calpain-dependent proteolysis of PKA RII subunits [75] and downregulation of PKA O-GlcNAcylation [77].”
BackgroundInfluentialGomes, J. R., Costa, J. T., Melo, C. V., Felizzi, F., Monteiro, P., Pinto, M. J., Inácio, A. R., Wieloch, T., Almeida, R. D., Grãos, M., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0374-12.2012 · Cited by 92 · cited 2×
“First, an inversion of the physiological ratio of the TrkB encoding mRNAs which favours the expression of the isoform TrkB-T1 over TrkB-FL (Figure 2b) [32,33].”
BackgroundMaussion, G., Yang, J., Yerko, V., Barker, P., Mechawar, N., Ernst, C., & Turecki, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039301 · Cited by 91 · cited 1×
“This decrease in TrkB isoforms has been associated with a failure of the E3 ligase c-Cbl, a protein involved in TrkB-FL stabilization by ubiquitination [156], and an increase of Hsa-miR-185*, a microRNA responsible for the regulation of TrkB-T1 expression [157].”
BackgroundIn Vivo Theranostics at the Peri-Infarct Region in Cerebral Ischemia
Agulla, J., Brea, D., Campos, F., Sobrino, T., Argibay, B., Al-Soufi, W., Blanco, M., Castillo, J., & Ramos-Cabrer, P. (2014) · Theranostics · doi:10.7150/thno.7088 · Cited by 90 · cited 1×
“Thus, a theranostic nanocarrier that specifically targets the peri-infarct tissue in cerebral ischemia has been developed [186].”
BackgroundNeurotrophin signaling in cancer stem cells
Chopin, V., Lagadec, C. H., Toillon, R., & Bourhis, X. L. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2156-7 · Cited by 90
Korkmaz, O. T., Aytan, N., Carreras, I., Choi, J.-K., Kowall, N. W., Jenkins, B. G., & Dedeoglu, A. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.02.058 · Cited by 88 · cited 3×
“Thus, intrathecally administered BDNF in patients of amyotrophic lateral sclerosis (ALS) did not show significant effects on motor function and survival [1] or autonomic nervous system function [2].”
BackgroundHarris, N. M., Ritzel, R., Mancini, N. S., Jiang, Y., Yi, X., Manickam, D. S., Banks, W. A., Kabanov, A. V., McCullough, L. D., & Verma, R. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.09.003 · Cited by 88 · cited 1×
“More delayed treatment (12 h) still improves memory/cognition and reduces post-stroke depression but has no effect on infarct size [184].”
BackgroundShuttle‐Mediated Drug Delivery to the Brain
Malakoutikhah, M., Teixidó, M., & Giralt, E. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006565 · Cited by 85 · cited 1×
“One of the more innovative ideas for the modulation of BDNF/TrkB downstream signalling pathways is shuttle-mediated drug delivery by conjugation of the therapeutic molecules to cell-penetrating peptides (CPPs) capable to cross the BBB and the cell membrane (reviewed by [205]).”
BackgroundMariga, A., Mitre, M., & Chao, M. V. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.009 · Cited by 83 · cited 1×
“An alternative to TrkB agonists for neuroprotection is transactivation of Trk receptors by ligands of G protein-coupled receptors (GPCRs), dopamine or glucocorticoids (reviewed in reference [202]).”
BackgroundBaydyuk, M., Nguyen, M. T., & Xu, B. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2010.12.018 · Cited by 79
Visanji, N. P., Orsi, A., Johnston, T. H., Howson, P. A., Dixon, K., Callizot, N., Brotchie, J. M., & Rees, D. D. (2008) · The FASEB Journal · doi:10.1096/fj.07-095398 · Cited by 78 · cited 1×
“Finally, another promising approach has been the development of a small-size orally active molecule (PYM50028) able to increase levels of GDNF and BDNF in the striatum of MPTP-lesioned mice, considered as a good candidate for neuroprotection and neurorepair in PD [194].”
BackgroundNeurotrophin signaling endosomes: biogenesis, regulation, and functions
Yamashita, N., & Kuruvilla, R. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2016.06.004 · Cited by 78 · cited 1×
“Additionally, early endosomes (also known as signalling endosomes) are dynamic structures that can modify their protein components in accordance to their cellular destinies: retrograde transport to neuronal soma to propagate the BDNF signal, recycling back to plasma membrane or lysosomal degradation [18].”
BackgroundWu, L. L.-Y., Fan, Y., Li, S., Li, X.-J., & Zhou, X.-F. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.073197 · Cited by 77 · cited 1×
“Thus, the tighter bond of mutant Htt to HAP1 in HD brain decreases this protein interaction with pro-BDNF [99].”
Backgroundvon Bohlen und Halbach, O., Minichiello, L., & Unsicker, K. (2005) · The FASEB Journal · doi:10.1096/fj.05-3845fje · Cited by 77
Neurotrophic Effect of a Novel TrkB Agonist on Retinal Ganglion Cells
Hu, Y., Cho, S., & Goldberg, J. L. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4450 · Cited by 75 · cited 1×
“7,8-DHF acts as a selective and efficient TrkB agonist and presents neuroprotective effects in excitotoxic processes induced in vitro [199] or using in vivo models of brain ischemia [198], AD [200], ALS [201] or PD [198], among others.”
BackgroundSlevin, M., Krupinski, J., Slowik, A., Rubio, F., Szczudlik, A., & Gaffney, J. (2000) · NeuroReport · doi:10.1097/00001756-200008210-00030 · Cited by 74 · cited 1×
“However, sustained ERK1/2 phosphorylation has been detected in the penumbra area after acute ischemic stroke in humans [38] and animal models [39], where it seems to contribute to brain injury [40].”
BackgroundChan, A., Yan, J., Csurhes, P. A., Greer, J. M., & McCombe, P. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.06.013 · Cited by 72 · cited 1×
“However, BDNF has never been measured in the postmortem brains of stroke patients, although a slight increase in circulating neurotrophin levels observed after stroke could mirror brain levels [27].”
BackgroundHuang, S.-H., Wang, J., Sui, W.-H., Chen, B., Zhang, X.-Y., Yan, J., Geng, Z., & Chen, Z.-Y. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3256-12.2013 · Cited by 70 · cited 2×
“Furthermore, induction by mutant Htt of deficient Rab11 activity [114] could reduce TrkB cell surface availability since this GTPase is typically involved in TrkB-FL endosomal recycling [21,115].”
BackgroundZhao, L. R., Mattsson, B., & Johansson, B. B. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00023-3 · Cited by 70 · cited 1×
“However, several studies have concluded that BDNF is not involved in post-stroke functional recovery [30,31].”
BackgroundIncreases in Two Truncated TrkB Isoforms in the Prefrontal Cortex of People With Schizophrenia
Wong, J., Rothmond, D. A., Webster, M. J., & Shannon Weickert, C. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr070 · Cited by 70 · cited 1×
“By contrast, expression of the truncated isoforms TrkB-Shc and TrkB-T1 undergoes an increase in the brain of schizophrenic subjects [167].”
BackgroundAmoureux, M., Gool, D. V., Herrero, M. T., Dom, R., Colpaert, F. C., & Pauwels, P. J. (1997) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815170 · Cited by 68 · cited 1×
“The decrease of BDNF mRNA is an important mechanism of neurotrophin loss in AD brain (Figure 3a), observed in hippocampus [53], basal forebrain [54], and temporal [55] and parietal cortices [56].”
BackgroundDysfunctional mitochondria uphold calpain activation: Contribution to Parkinson's disease pathology
Esteves, A. R., Arduíno, D. M., Swerdlow, R. H., Oliveira, C. R., & Cardoso, S. M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.011 · Cited by 67
Jin, N., Qian, W., Yin, X., Zhang, L., Iqbal, K., Grundke-Iqbal, I., Gong, C.-X., & Liu, F. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1227 · Cited by 67
Aging Triggers a Repressive Chromatin State at Bdnf Promoters in Hippocampal Neurons
Palomer, E., Martín-Segura, A., Baliyan, S., Ahmed, T., Balschun, D., Venero, C., Martin, M. G., & Dotti, C. G. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.028 · Cited by 66
Tanaka, K., Nagata, E., Suzuki, S., Dembo, T., Nogawa, S., & Fukuuchi, Y. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01263-3 · Cited by 64 · cited 1×
“Since BDNF expression is CREB-regulated, this result supports the neurotrophin expression pattern observed after stroke (Figure 2i) [44].”
ResultNguyen, K. Q., Rymar, V. V., & Sadikot, A. F. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00037 · Cited by 64
Ipsilateral versus contralateral spontaneous post-stroke neuroplastic changes: Involvement of BDNF?
Madinier, A., Bertrand, N., Rodier, M., Quirié, A., Mossiat, C. M., Prigent‐Tessier, A., Marie, C., & Garnier, P. E. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.11.054 · Cited by 62 · cited 1×
“In animal models of ischemic stroke, a permanent BDNF reduction has been observed in the infarct core, while rapid upregulation of neurotrophin expression lasting for several days was found in the penumbra [25,26].”
BackgroundDecreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer’s disease
Kim, S. H., Nairn, A. C., Cairns, N. J., & Lübec, G. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_21 · Cited by 57 · cited 1×
“Additionally, protein kinase A (PKA), a major CREB regulator, is inactivated in the temporal cortex of AD patients [74,75] by Aβ action [76].”
BackgroundHypo-Osmolar Stress Induces p75NTR Expression by Activating Sp1-Dependent Transcription
Ramos, A., Chi Ho, W., Forte, S., Dickson, K., Boutilier, J., Favell, K., & Barker, P. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4806-06.2007 · Cited by 57 · cited 1×
“The upregulation of Sp1 observed in cellular and transgenic models of HD [111] could underlie the increased expression of p75NTR since this gene is regulated by this transcription factor [112].”
BackgroundMichalski, B., Corrada, M. M., Kawas, C. H., & Fahnestock, M. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.022 · Cited by 56
Díaz‐Rodríguez, E., Cabrera, N., Esparís‐Ogando, A., Montero, J. C., & Pandiella, A. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00552.x · Cited by 55 · cited 1×
“It will be interesting to investigate if the intracellular TrkB-FL calpain fragment maintains PLCγ interaction, as described for similar TrkA fragments [180], and further exacerbates epileptogenesis.”
BackgroundProteolytic cleavages give receptor tyrosine kinases the gift of ubiquity
Ancot, F., Foveau, B., Lefebvre, J., Leroy, C., & Tulasne, D. (2009) · Oncogene · doi:10.1038/onc.2009.88 · Cited by 55 · cited 1×
“It has been previously suggested that the proteolytic fragments generated from receptor tyrosine kinases might regulate cell functions such as transcription or survival/apoptosis balance [69].”
BackgroundHuang, S.-H., Zhao, L., Sun, Z.-P., Li, X.-Z., Geng, Z., Zhang, K.-D., Chao, M. V., & Chen, Z.-Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809763200 · Cited by 54
Benisty, S., Boissière‐Michot, F., Faucheux, B. A., Agid, Y., & Hirsch, É. C. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00126-2 · Cited by 54
MeCP2: a novel Huntingtin interactor
McFarland, K. N., Huizenga, M. N., Darnell, S. B., Sangrey, G. R., Berezovska, O., Cha, J.-H. J., Outeiro, T. F., & Sadri-Vakili, G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt499 · Cited by 54 · cited 1×
“Additionally, the expanded polyQ Htt generates a more repressive transcriptional environment for Bdnf by recruiting the methyl-CpG binding protein 2 (MeCP2) to promoter IV [107], also sequestering the transcriptional coactivator CREB binding protein (CBP) [108].”
BackgroundCampos, C., Rocha, N. B. F., Lattari, E., Paes, F., Nardi, A. E., & Machado, S. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1179582 · Cited by 54
Kinase Signalling in Huntington's Disease
Bowles, K. R., & Jones, L. (2014) · Journal of Huntington's Disease · doi:10.3233/jhd-140106 · Cited by 53 · cited 1×
“However, the characterization of kinase signalling in HD models is still controversial [120], highlighting the need to redefine the timeline of the deficits in neurotrophic effectors in order to develop therapies to treat involuntary movement in symptomatic HD patients.”
BackgroundSerine 421 regulates mutant huntingtin toxicity and clearance in mice
Kratter, I. H., Zahed, H., Lau, A., Tsvetkov, A. S., Daub, A. C., Weiberth, K. F., Gu, X., Saudou, F., Humbert, S., Yang, X. W., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci80339 · Cited by 53 · cited 1×
“The phosphorylation of wild-type Htt in Ser421 by Akt promotes the anterograde movement of vesicles [101], mediates IGF-1 neuroprotective effects in HD [102] and mitigates the toxicity of mutant Htt by increasing its proteasome-dependent turnover [103].”
BackgroundSasaki, T., Han, F., Shioda, N., Moriguchi, S., Kasahara, J., Ishiguro, K., & Fukunaga, K. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.009 · Cited by 52 · cited 1×
“Transient focal ischemia tends to activate GSK-3β and subsequently induce apoptotic cell death [42], whereas permanent cerebral ischemia rapidly suppresses it for 24 h after damage [43].”
BackgroundOhira, K., Shimizu, K., & Hayashi, M. (1999) · Developmental Brain Research · doi:10.1016/s0165-3806(98)00151-5 · Cited by 51 · cited 1×
“Interestingly, TrkB expression [14] and responsiveness to BDNF are developmentally regulated [15,16].”
BackgroundBoger, H. A., Mannangatti, P., Samuvel, D. J., Saylor, A. J., Bender, T. S., McGinty, J. F., Fortress, A. M., Zaman, V., Huang, P., Middaugh, L. D., et al. (2011) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00654.x · Cited by 50 · cited 1×
“Actually, inhibition of BDNF expression or TrkB insufficiency cause selective loss of SNpc dopaminergic neurons [128–130] and exacerbate motor dysfunction in aged animals [131].”
BackgroundDi Lieto, A., Rantamäki, T., Vesa, L., Yanpallewar, S., Antila, H., Lindholm, J., Rios, M., Tessarollo, L., & Castrén, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032869 · Cited by 47 · cited 3×
“However, the postnatal decline of BDNF-induced TrkB-FL phosphorylation is not a consequence of the coincidental increase of TrkB-T1 expression or due to structural receptor modifications preventing BDNF binding [16].”
BackgroundKim, S., Park, J.-M., Moon, J., & Choi, H. J. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.009 · Cited by 45 · cited 1×
“α-synuclein also contributes to downregulation of neurotrophin transcription by suppression of Elk-1 activity [140] and competition in nuclei with CREB for binding to CREs in promoter regions [141].”
BackgroundFenner, M. E., Achim, C. L., & Fenner, B. M. (2013) · Journal of Molecular Histology · doi:10.1007/s10735-013-9562-z · Cited by 42 · cited 3×
“In contrast, levels of TrkB-FL mRNA are normal in surviving SNpc neurons of PD brains [124] while only minimal regional changes are observed in protein levels [125].”
BackgroundGan, K. J., & Silverman, M. A. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-12-1612 · Cited by 41
Wong, J., Garner, B., Halliday, G. M., & Kwok, J. B. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07873.x · Cited by 40 · cited 2×
“In addition, Aβ might be also inducing the upregulation of truncated TrkB isoforms in AD by transcriptional mechanisms [68,70].”
BackgroundWong, J., Higgins, M. J., Halliday, G. M., & Garner, B. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.037 · Cited by 40
Tyrosine phosphatase SHP‐2 is a mediator of activity‐dependent neuronal excitotoxicity
Rusanescu, G., Yang, W., Bai, A., Neel, B. G., & Feig, L. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600522 · Cited by 39 · cited 1×
“Additionally, under excitotoxic conditions, TrkB-FL activity is also impaired by phosphatase Shp-2 (Src homology-2 domain-containing phosphatase-2) dephosphorylation of residue Tyr515 (Figure 2h) [36].”
BackgroundTejeda, G. S., Ayuso‐Dolado, S., Arbeteta, R., Esteban-Ortega, G. M., Vidaurre, Ó. G., & Díaz‐Guerra, M. (2015) · The Journal of Pathology · doi:10.1002/path.4684 · Cited by 37 · cited 4×
“In a model of permanent ischemia in mice, RIP highly contributes to TrkB-T1 downregulation while it is a secondary mechanism for TrkB-FL, which is mainly processed by calpain [34].”
BackgroundInfluentialSelf-citationAngelo, M. F., Aviles‐Reyes, R. X., Villarreal, A., Barker, P., Reinés, A. G., & Ramos, A. J. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21993 · Cited by 36
Xu, W., Zhou, M., & Baudry, M. (2007) · The Neuroscientist · doi:10.1177/1073858407309762 · Cited by 35 · cited 1×
“For example, this has been demonstrated for STEP (striatal-enriched protein tyrosin phosphatase) [206], an important regulator of synaptic signalling proteins or the NMDAR, or the metabotropic glutamate receptor 1 [207].”
Background
Cited by
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750
Wang, H., Xu, J., Lazarovici, P., Quirion, R., & Zheng, W. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00255 · Cited by 436
Tartt, A. N., Mariani, M. B., Hen, R., Mann, J. J., & Boldrini, M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01520-y · Cited by 408
“, MAPK/ERK, PI3K, mTOR) [143] responsible for spine enlargement and glutamate sensitivity [144] (Fig.”
BackgroundEsvald, E.-E., Tuvikene, J., Sirp, A., Patil, S., Bramham, C. R., & Timmusk, T. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0367-19.2019 · Cited by 248
“Dysregulation of BDNF expression in a brain region and cell type-specific manner has been implicated in various neurological and neurodevelopmental disorders and in various neurodegenerative diseases (Zuccato and Cattaneo, 2009; Autry and Monteggia, 2012; Tejeda and Díaz-Guerra, 2017).”
BackgroundThe Role of BDNF in the Neuroimmune Axis Regulation of Mood Disorders
Jin, Y., Sun, L. H., Yang, W., Cui, R. J., & Xu, S. B. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00515 · Cited by 198
“Signaling Pathway of BDNF in Depression Tyrosine receptor kinase B (TrkB), a member of the tyrosine kinase family, can specifically bind to BDNF with a high affinity (41).”
Background
Metadata
- Authors
- Tejeda, G., & Díaz-Guerra, M.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Instituto de Investigaciones Biomédicas “Alberto Sols”, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Arturo Duperier 4, 28029 Madrid, Spain
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-01-28
- Volume
- 18
- Issue
- 2
- Pages
- 268
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5343804
- OpenAlex
- W2581435615
- Cited by
- 126
- References
- 212
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 16 · 2023: 16 · 2022: 13 · 2021: 13 · 2020: 20 · 2019: 13 · 2018: 10 · 2017: 4
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- Funders
- Ministerio de Economía y Competitividad, Spain (BFU2013-43808-R)
- Fundación Mutua Madrileña, Spain (201322001)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- brain-derived neurotrophic factor, TrkB receptor, BDNF/TrkB signaling, neurotrophin signaling, neurological disorders, mental illness, neurotrophic therapy, neuroplasticity, cell death
- MeSH terms
- Animals, Mental Disorders, Humans, Nervous System, Signal Transduction, Brain-Derived Neurotrophic Factor, Receptor, trkB, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.